Symmetry Medical Inc. 4
Accession 0001181431-05-042053
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 4:09 PM ET
Size
39.8 KB
Accession
0001181431-05-042053
Insider Transaction Report
- Exercise of In-Money
Common Stock
2005-07-21+47,974→ 69,676 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21$0.01/sh+21,702$217→ 21,702 total(indirect: See Footnote) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21$0.01/sh−21,702$217→ 88,282 total(indirect: See Footnote)Exercise: $0.01Exp: 2013-06-11→ Common Stock (21,702 underlying) - Sale
Common Stock
2005-07-22$21.25/sh−69,676$1,480,524→ 10,666,300 total(indirect: See Footnote) - Sale
Common Stock
2005-07-22$21.25/sh−8,093,280$171,971,679→ 11,804,695 total(indirect: See Footnote) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21−47,974→ 0 total(indirect: See Footnote)Exp: 2013-06-11→ Common Stock (47,974 underlying) - Other
Common Stock
2005-07-22−798,947→ 0 total(indirect: See Footnote) - Other
Common Stock
2005-07-22−11,804,695→ 0 total(indirect: See Footnote)
- 52,828(indirect: See Footnote)
Common Stock
- 19,043(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (19,043 underlying) - 461(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (461 underlying) - 8,306(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (8,306 underlying) - 77,893(indirect: See Footnote)
Common Stock
- 1,057(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (1,057 underlying)
- Sale
Common Stock
2005-07-22$21.25/sh−8,093,280$171,971,679→ 11,804,695 total(indirect: See Footnote) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21$0.01/sh−21,702$217→ 88,282 total(indirect: See Footnote)Exercise: $0.01Exp: 2013-06-11→ Common Stock (21,702 underlying) - Other
Common Stock
2005-07-22−798,947→ 0 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21$0.01/sh+21,702$217→ 21,702 total(indirect: See Footnote) - Other
Common Stock
2005-07-22−11,804,695→ 0 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21+47,974→ 69,676 total(indirect: See Footnote) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21−47,974→ 0 total(indirect: See Footnote)Exp: 2013-06-11→ Common Stock (47,974 underlying) - Sale
Common Stock
2005-07-22$21.25/sh−69,676$1,480,524→ 10,666,300 total(indirect: See Footnote)
- 1,057(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (1,057 underlying) - 461(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (461 underlying) - 77,893(indirect: See Footnote)
Common Stock
- 19,043(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (19,043 underlying) - 8,306(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (8,306 underlying) - 52,828(indirect: See Footnote)
Common Stock
- Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21−47,974→ 0 total(indirect: See Footnote)Exp: 2013-06-11→ Common Stock (47,974 underlying) - Sale
Common Stock
2005-07-22$21.25/sh−8,093,280$171,971,679→ 11,804,695 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21+47,974→ 69,676 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21$0.01/sh+21,702$217→ 21,702 total(indirect: See Footnote) - Other
Common Stock
2005-07-22−11,804,695→ 0 total(indirect: See Footnote) - Sale
Common Stock
2005-07-22$21.25/sh−69,676$1,480,524→ 10,666,300 total(indirect: See Footnote) - Other
Common Stock
2005-07-22−798,947→ 0 total(indirect: See Footnote) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21$0.01/sh−21,702$217→ 88,282 total(indirect: See Footnote)Exercise: $0.01Exp: 2013-06-11→ Common Stock (21,702 underlying)
- 52,828(indirect: See Footnote)
Common Stock
- 8,306(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (8,306 underlying) - 461(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (461 underlying) - 19,043(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (19,043 underlying) - 77,893(indirect: See Footnote)
Common Stock
- 1,057(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (1,057 underlying)
- Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21$0.01/sh−21,702$217→ 88,282 total(indirect: See Footnote)Exercise: $0.01Exp: 2013-06-11→ Common Stock (21,702 underlying) - Other
Common Stock
2005-07-22−11,804,695→ 0 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21+47,974→ 69,676 total(indirect: See Footnote) - Sale
Common Stock
2005-07-22$21.25/sh−69,676$1,480,524→ 10,666,300 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21$0.01/sh+21,702$217→ 21,702 total(indirect: See Footnote) - Sale
Common Stock
2005-07-22$21.25/sh−8,093,280$171,971,679→ 11,804,695 total(indirect: See Footnote) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21−47,974→ 0 total(indirect: See Footnote)Exp: 2013-06-11→ Common Stock (47,974 underlying) - Other
Common Stock
2005-07-22−798,947→ 0 total(indirect: See Footnote)
- 8,306(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (8,306 underlying) - 461(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (461 underlying) - 52,828(indirect: See Footnote)
Common Stock
- 77,893(indirect: See Footnote)
Common Stock
- 19,043(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (19,043 underlying) - 1,057(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (1,057 underlying)
- Exercise of In-Money
Common Stock
2005-07-21$0.01/sh+21,702$217→ 21,702 total(indirect: See Footnote) - Other
Common Stock
2005-07-22−798,947→ 0 total(indirect: See Footnote) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21−47,974→ 0 total(indirect: See Footnote)Exp: 2013-06-11→ Common Stock (47,974 underlying) - Sale
Common Stock
2005-07-22$21.25/sh−69,676$1,480,524→ 10,666,300 total(indirect: See Footnote) - Other
Common Stock
2005-07-22−11,804,695→ 0 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21+47,974→ 69,676 total(indirect: See Footnote) - Sale
Common Stock
2005-07-22$21.25/sh−8,093,280$171,971,679→ 11,804,695 total(indirect: See Footnote) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21$0.01/sh−21,702$217→ 88,282 total(indirect: See Footnote)Exercise: $0.01Exp: 2013-06-11→ Common Stock (21,702 underlying)
- 52,828(indirect: See Footnote)
Common Stock
- 8,306(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (8,306 underlying) - 461(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (461 underlying) - 1,057(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (1,057 underlying) - 19,043(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (19,043 underlying) - 77,893(indirect: See Footnote)
Common Stock
- Sale
Common Stock
2005-07-22$21.25/sh−69,676$1,480,524→ 10,666,300 total(indirect: See Footnote) - Other
Common Stock
2005-07-22−798,947→ 0 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21$0.01/sh+21,702$217→ 21,702 total(indirect: See Footnote) - Exercise of In-Money
Common Stock
2005-07-21+47,974→ 69,676 total(indirect: See Footnote) - Sale
Common Stock
2005-07-22$21.25/sh−8,093,280$171,971,679→ 11,804,695 total(indirect: See Footnote) - Other
Common Stock
2005-07-22−11,804,695→ 0 total(indirect: See Footnote) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21$0.01/sh−21,702$217→ 88,282 total(indirect: See Footnote)Exercise: $0.01Exp: 2013-06-11→ Common Stock (21,702 underlying) - Exercise of In-Money
Common Stock (Warrant right to buy)
2005-07-21−47,974→ 0 total(indirect: See Footnote)Exp: 2013-06-11→ Common Stock (47,974 underlying)
- 19,043(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (19,043 underlying) - 1,057(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exercise: $0.01Exp: 2013-06-11→ Common Stock (1,057 underlying) - 52,828(indirect: See Footnote)
Common Stock
- 77,893(indirect: See Footnote)
Common Stock
- 8,306(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (8,306 underlying) - 461(indirect: See Footnote)
Common Stock (Warrant right to buy)
Exp: 2013-06-11→ Common Stock (461 underlying)
Footnotes (11)
- [F1]Following the dispositions set forth in this Form 4, Olympus/Symmetry Holdings LLC was the record owner of 0 shares of common stock, Olympus Growth Fund III, L.P. was the record owner of 10,666,300 shares of common stock and currently exercisable warrants to purchase 88,282 shares of common stock, Olympus Growth Co-Investment Fund III, L.P. was the record owner of currently exercisable warrants to purchase 27,349 shares of common stock, Olympus Executive Fund, L.P. was the record owner of 77,893 shares of common stock and currently exercisable warrants to purchase 1,518 shares of common stock and OGP III, LLC was the record owner of 52,828 shares of common stock. (continued footnote 2)
- [F10]Currently exercisable.
- [F11]Represents shares directly owned by OGP III, LLC. Shares beneficially owned, both directly and indirectly, by OPG III, LLC are beneficially owned indirectly by RSM, L.L.C., the managing member of OGP III, LLC; and by Mr. Robert S. Morris, the managing member of RSM, L.L.C.
- [F2]Mr. Morris, a member of our board of directors, is the managing partner of Olympus Partners and the Managing Member of RSM, L.L.C., and, in such capacities, has voting and investment power with respect to all shares held by the Olympus funds and has a pecuniary interest in certain of those shares. Mr. Morris disclaims beneficial ownership of the common stock owned by the above entities, except to the extent of his proportionate pecuniary interest therein.
- [F3]Exercise price of .000128 per share.
- [F4]On July 22, 2005, Olympus/Symmetry Holdings LLC made a pro-rata distribution of common stock, without consideration, to its members, which include Olympus Growth Fund III, L.P. , which received 10,666,300 shares, Olympus Growth Co-Investment Fund III, which received 798,947 shares and Olympus Executive Fund, L.P., which received 77,893 shares.
- [F5]On July 22, 2005, Olympus Growth Co-Investment Fund III, L.P. made a pro-rata distribution of common stock, without consideration, to its partners, which include OGP III, LLC, which received 52,828 shares. OGP III, LLC is the general partner of Olympus Co-Investment Fund III, L.P. and is also the general partner of Olympus Growth Fund III, L.P., which is the managing member of Olympus/Symmetry Holdings LLC. The receipt of such shares by OGP III, LLC represents a change in the form of beneficial ownership.
- [F6]Represents shares or warrants, as applicable, directly owned by Olympus Growth Fund III, L.P. Shares beneficially owned, both directly and indirectly, by Olympus Growth Fund III, L.P. and by Olympus Growth Co-Investment Fund III, L.P. are beneficially owned indirectly by OGP III, LLC, the General Partner of each; by RSM, L.L.C., the Managing Member of OGP III, LLC; and by Mr. Robert S. Morris, the Managing Member of RSM, L.L.C.
- [F7]Represents shares directly owned by Olympus/Symmetry Holdings LLC. Shares beneficially owned directly by Olympus/Symmetry Holdings LLC were beneficially owned indirectly by Olympus Growth Fund III, L.P., its Managing Member; by OGP III, LLC, the General Partner of Olympus Growth Fund III, L.P.; by RSM, L.L.C., the Managing Member of OGP, LLC; and by Robert S Morris, the Managing Member of RSM, L.L.C.
- [F8]Represents shares directly owned by Olympus Growth Co-Investment Fund III, L.P. Shares beneficially owned, both directly and indirectly, by Olympus Growth Fund III, L.P. and by Olympus Growth Co-Investment Fund III, L.P. are beneficially owned indirectly by OGP III, LLC, the General Partner of each; by RSM, L.L.C., the Managing Member of OGP III, LLC; and by Mr. Robert S. Morris, the Managing Member of RSM, L.L.C.
- [F9]Represents shares directly owned by Olympus Executive Fund, L.P. Shares beneficially owned directly by Olympus Executive Fund, L.P. are beneficially owned indirectly by OEF, L.P., its General Partner; by RSM, L.L.C., a General Partner of OEF, L.P.; and by Mr. Morris, the Managing Partner of OEF, L.P. through his capacity as Managing Member of RSM, L.L.C.
Documents
Issuer
Symmetry Medical Inc.
CIK 0001292055
Related Parties
1- filerCIK 0001292055
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 4:09 PM ET
- Size
- 39.8 KB